Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease and pregnancy.

L I Golbe

    Neurology
    |July 1, 1987
    PubMed
    Summary

    Pregnancy after Parkinson's disease (PD) onset can lead to symptom worsening, but generally not increased disability or birth defects. Amantadine use in early pregnancy was linked to complications like miscarriage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

    Neurology·2008
    Same author

    Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

    Neurology·2006
    Same author

    BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.

    Neurology·2005
    Same author

    Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.

    Movement disorders : official journal of the Movement Disorder Society·2005
    Same author

    A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.

    Neurology·2003
    Same author

    Segregation analysis of Parkinson disease revealing evidence for a major causative gene.

    American journal of medical genetics·2002

    Area of Science:

    • Neurology
    • Obstetrics
    • Reproductive Health

    Background:

    • Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
    • The impact of pregnancy on PD progression and vice versa is not well understood.
    • Limited data exists on obstetric outcomes and fetal development in PD patients.

    Purpose of the Study:

    • To investigate the interaction between pregnancy and Parkinson's disease.
    • To assess obstetric complications and outcomes in women with PD.
    • To evaluate the effect of pregnancy on PD symptom severity and disability.

    Main Methods:

    • Retrospective interviews with 18 women diagnosed with Parkinson's disease.
    • Data collection on 24 pregnancies occurring after PD symptom onset.
    • Analysis of pregnancy outcomes, including miscarriages, abortions, and term pregnancies.
    • Assessment of medication use (amantadine) during pregnancy.
    • Evaluation of changes in PD symptoms and overall disability post-pregnancy.

    Main Results:

    • Conception occurred at a mean age of 34.7 years.
    • Among 24 pregnancies, there were 3 miscarriages, 4 elective abortions, and 17 term pregnancies.
    • Amantadine use in the first trimester was associated with obstetric complications, including miscarriage.
    • Ten of 17 completed pregnancies resulted in permanent worsening of PD symptoms, without affecting overall disability.
    • No excess incidence of obstetric complications or fetal defects was observed in the overall cohort.

    Conclusions:

    • Pregnancy in women with Parkinson's disease can lead to temporary or permanent worsening of motor symptoms.
    • Amantadine use during the first trimester may increase the risk of obstetric complications.
    • Overall, pregnancy does not appear to significantly increase disability or the incidence of birth defects in PD patients.
    • Further research is needed to guide management of PD during pregnancy.

    Related Experiment Videos